Cognitive decline is a frequent but undervalued aspect of multiple sclerosis (MS). Currently, it remains unclear what the strongest determinants of cognitive dysfunction are, with grey matter damage most directly related to cognitive impairment. Multi-parametric studies seem to indicate that individual factors of MS-pathology are highly interdependent causes of grey matter atrophy and permanent brain damage. They are associated with intermediate functional effects (e.g. in functional MRI) representing a balance between disconnection and (mal) adaptive connectivity changes. Therefore, a more comprehensive MRI approach is warranted, aiming to link structural changes with functional brain organization. To better understand the disconnection sy...
Multiple sclerosis (MS) is characterized by extensive damage in the central nervous system. Within t...
Objective: To investigate default-mode network (DMN) and frontoparietal network (FPN) dysfunction in...
Cognitive impairment may result in significant disability in patients with Multiple Sclerosis (MS). ...
Cognitive decline is a frequent but undervalued aspect of multiple sclerosis (MS). Currently, it rem...
Item does not contain fulltextIntroduction: Disruptions in functional brain network organization see...
International audienceSevere cognitive impairment involving multiple cognitive domains can occur ear...
Contains fulltext : 234384.pdf (Publisher’s version ) (Open Access)Background: Cog...
From PubMed via Jisc Publications RouterHistory: received 2021-02-05, accepted 2021-09-13Publication...
The pathophysiology of cognitive dysfunction in multiple sclerosis (MS) has not been elucidated. Pos...
Background: Previous studies have demonstrated extensive functional network disturbances in patients...
The relation between pathological findings and clinical and cognitive decline in Multiple Sclerosis ...
Patients with multiple sclerosis (MS) display reduced structural connectivity among brain regions, b...
BACKGROUND: Coordinated patterns of gray matter morphology can be represented as networks, and netwo...
The relation between pathological findings and clinical and cognitive decline in Multiple Sclerosis ...
The pathophysiology of cognitive dysfunction in multiple sclerosis (MS) is still unclear. This magne...
Multiple sclerosis (MS) is characterized by extensive damage in the central nervous system. Within t...
Objective: To investigate default-mode network (DMN) and frontoparietal network (FPN) dysfunction in...
Cognitive impairment may result in significant disability in patients with Multiple Sclerosis (MS). ...
Cognitive decline is a frequent but undervalued aspect of multiple sclerosis (MS). Currently, it rem...
Item does not contain fulltextIntroduction: Disruptions in functional brain network organization see...
International audienceSevere cognitive impairment involving multiple cognitive domains can occur ear...
Contains fulltext : 234384.pdf (Publisher’s version ) (Open Access)Background: Cog...
From PubMed via Jisc Publications RouterHistory: received 2021-02-05, accepted 2021-09-13Publication...
The pathophysiology of cognitive dysfunction in multiple sclerosis (MS) has not been elucidated. Pos...
Background: Previous studies have demonstrated extensive functional network disturbances in patients...
The relation between pathological findings and clinical and cognitive decline in Multiple Sclerosis ...
Patients with multiple sclerosis (MS) display reduced structural connectivity among brain regions, b...
BACKGROUND: Coordinated patterns of gray matter morphology can be represented as networks, and netwo...
The relation between pathological findings and clinical and cognitive decline in Multiple Sclerosis ...
The pathophysiology of cognitive dysfunction in multiple sclerosis (MS) is still unclear. This magne...
Multiple sclerosis (MS) is characterized by extensive damage in the central nervous system. Within t...
Objective: To investigate default-mode network (DMN) and frontoparietal network (FPN) dysfunction in...
Cognitive impairment may result in significant disability in patients with Multiple Sclerosis (MS). ...